Literature DB >> 21748512

Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA.

Timothy M Diiorio1, Justin D Burkholder, Robert P Good, Javad Parvizi, Peter F Sharkey.   

Abstract

BACKGROUND: Numerous reports suggest the application of platelet-rich plasma (PRP) during TKA may decrease postoperative bleeding. Because excessive bleeding can increase postoperative pain and inflammation, use of PRP also reportedly decreases the need for narcotics and increases speed of recovery after TKA. Because previous investigations of PRP and TKA reflect a weak level of medical evidence, we sought to confirm these findings. QUESTIONS/PURPOSES: We asked whether an intraoperative application of PRP gel to the deep wound reduced postoperative bleeding after TKA.
METHODS: We retrospectively reviewed the charts of all 134 patients who received an intraoperative application of PRP during TKA from November 2009 to April 2010 and all 139 patients undergoing TKA who did not receive PRP between September 2009 to November 2009. Patients' charts were reviewed to identify detailed data, including hemoglobin level, ROM, postoperative narcotic use, and length of hospital stay. Blood loss was determined by the hemoglobin drop on postoperative Day 2.
RESULTS: The blood loss between study groups was similar (3.6 g/dL [study] versus 3.8 g/dL [controls]). Differences in passive ROM (88° versus 88°), narcotic requirement (27 versus 32 morphine equivalent), and length of stay (2.4 versus 2.6 days) were also similar.
CONCLUSION: We found no clinically important differences in patients who received an intraoperative application of PRP compared with patients who did not receive PRP and therefore could not confirm the findings of previous studies.

Entities:  

Mesh:

Year:  2012        PMID: 21748512      PMCID: PMC3237982          DOI: 10.1007/s11999-011-1972-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study.

Authors:  O Levy; U Martinowitz; A Oran; C Tauber; H Horoszowski
Journal:  J Bone Joint Surg Am       Date:  1999-11       Impact factor: 5.284

2.  Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial.

Authors:  G J Wang; D S Hungerford; C G Savory; A G Rosenberg; M A Mont; S G Burks; S L Mayers; W D Spotnitz
Journal:  J Bone Joint Surg Am       Date:  2001-10       Impact factor: 5.284

3.  Autologous platelet gel in total knee arthroplasty: a prospective randomized study.

Authors:  Wieger G Horstmann; Robert Slappendel; Gijs G van Hellemondt; Ate W Wymenga; Nigel Jack; Peter A M Everts
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-07-18       Impact factor: 4.342

4.  Platelet-rich plasma application during closure following total knee arthroplasty.

Authors:  William J Berghoff; William S Pietrzak; Richard D Rhodes
Journal:  Orthopedics       Date:  2006-07       Impact factor: 1.390

5.  Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing.

Authors:  A G Mylod; M P France; D E Muser; J R Parsons
Journal:  J Bone Joint Surg Am       Date:  1990-08       Impact factor: 5.284

6.  Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty.

Authors:  P A M Everts; R J J Devilee; C Brown Mahoney; M Eeftinck-Schattenkerk; H A M Box; J T A Knape; A van Zundert
Journal:  Acta Anaesthesiol Scand       Date:  2006-05       Impact factor: 2.105

7.  Blood loss with total knee arthroplasty.

Authors:  A T Berman; A E Geissele; S J Bosacco
Journal:  Clin Orthop Relat Res       Date:  1988-09       Impact factor: 4.176

8.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis.

Authors:  Gary E Hill; William H Frawley; Karl E Griffith; John E Forestner; Joseph P Minei
Journal:  J Trauma       Date:  2003-05

9.  Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion.

Authors:  P A Lotke; V J Faralli; E M Orenstein; M L Ecker
Journal:  J Bone Joint Surg Am       Date:  1991-08       Impact factor: 5.284

10.  Treatment of infected knee arthroplasty.

Authors:  S Bengston; K Knutson; L Lidgren
Journal:  Clin Orthop Relat Res       Date:  1989-08       Impact factor: 4.176

View more
  5 in total

Review 1.  Considerations for the use of platelet-rich plasma in orthopedics.

Authors:  Taralyn M McCarrel; Nathan A Mall; Andrew S Lee; Brian J Cole; Davietta C Butty; Lisa A Fortier
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

Review 2.  Anaesthetics, steroids and platelet-rich plasma (PRP) in ultrasound-guided musculoskeletal procedures.

Authors:  Antonio Barile; Alice La Marra; Francesco Arrigoni; Silvia Mariani; Luigi Zugaro; Alessandra Splendiani; Ernesto Di Cesare; Alfonso Reginelli; Marcello Zappia; Luca Brunese; Ejona Duka; Giampaolo Carrafiello; Carlo Masciocchi
Journal:  Br J Radiol       Date:  2016-07-07       Impact factor: 3.039

3.  Use of a haemostatic matrix does not reduce blood loss in minimally invasive total knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Emmanuel Thienpont
Journal:  Blood Transfus       Date:  2015-01-26       Impact factor: 3.443

4.  Investigating the effect of autologous platelet-rich plasma on pain in patients with pilonidal abscess treated with surgical removal of extensive tissue.

Authors:  Mostafa Mehrabi Bahar; Mohsen Ali Akbarian; Ali Azadmand
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

5.  Platelet-rich plasma (PRP) applied during total knee arthroplasty.

Authors:  João Paulo Fernandes Guerreiro; Marcus Vinicius Danieli; Alexandre Oliveira Queiroz; Elenice Deffune; Rosana Rossi Ferreira
Journal:  Rev Bras Ortop       Date:  2015-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.